NCT05109663View on ClinicalTrials.gov

A Dose Escalation and Food Effect Study of SKLB1028 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions

Healthy Subjects

Interventions

DRUG

SKLB1028

SKLB1028, capsule, oral

Trial Locations (1)

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY